1-11 of 11
Qunyi Guo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrated genomic and tumor microenvironment subtyping refines risk stratification in primary central nervous system lymphoma

Free
Xianggui Yuan, Qian Luo, Yurong Huang, Chaoyi Li, Teng Yu, Shanshan Guo, Qunyi Guo, Xueli Jin, Jiefeng Tong, Aiqi Zhao, Wen Lei, Xian Li, Baizhou Li, Shumei Wei, Wenbin Qian, Yun Liang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5304.
https://doi.org/10.1182/blood-2025-5304
Published: 2025
Journal Articles

Adult hemophagocytic lymphohistiocytosis: A multicenter retrospective analysis of etiology and impact on survival in China

Free
Jingsong He, Lixia Zhu, Mengqi Xiong, Jianguo Zhang, Yinyi Zhang, Xin Guo, Linjie Li, Lihong Shou, Qunyi Guo, Shuangwei Ying, Li Li, YI LI, Zhen Cai, He Huang, Xiu-Jin Ye
Journal: Blood
Blood (2025) 146 (Supplement 1): 6549.
https://doi.org/10.1182/blood-2025-6549
Published: 2025
Journal Articles

Orelabrutinib, sintilimab, and temozolomide (OST) in relapsed/refractory primary central nervous system lymphoma

Free
Xianggui Yuan, Yurong Huang, Qunyi Guo, Yaping Xie, Nengwen Xu, Xueli Jin, Jiefeng Tong, Yun Liang, Wenbin Qian
Journal: Blood
Blood (2025) 146 (Supplement 1): 5461.
https://doi.org/10.1182/blood-2025-5461
Published: 2025
Journal Articles

BGB-3111-218: Single-arm, open-label, multicenter study of the Bruton tyrosine kinase (BTK) inhibitor zanubrutinib (zanu) in patients with CD79B-mutated Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

Free
Li Wang, Fei Li, Qingyuan Zhang, Hui Zhou, Ou Bai, Liping Su, Chunhong Hu, Zhiming Li, Kaiyang Ding, Qunyi Guo, Xiaoling Li, Xiaoxi Zhou, Wenjuan Yu, Shuhua Yi, Zhixia Wei, Wenbin Qian, Feiheng Chen, Guohui Cui, Zhiyu Liang, Qingchao Zeng, Jiaoyan Lyu, Yang Liu, Pan Zhang, Zhirong Shen, Zaixing Shi, Jing Rong, Keshu Zhou, Weili Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 3684.
https://doi.org/10.1182/blood-2025-3684
Published: 2025
Journal Articles

A prospective, multicenter study on stem cell mobilization using EAP regimen as first-line mobilization in patients with multiple myeloma and lymphoma

Free
Peipei Ye, Weiying Feng, Linjie Li, Lin Qingqing, Jie Jin, Huixian Hu, Hongyan Tong, Qunyi Guo, Sai Chen, Gongqiang Wu, Jiaping Fu, Liangshun You, Huang Li, Jing le, Huifang Jiang, Yangxi Jin, Jian Shen, Linlong Xu, Wanzhuo Xie, Dong Chen, Shuangyue Li, Chao Hu, Lihong Shou, Renzhi Pei, Jingcheng Zhang, Ying Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 4179.
https://doi.org/10.1182/blood-2025-4179
Published: 2025
Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Free
Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian
Journal: Blood
Blood (2024) 144 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2024-198485
Published: 2024
Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Free
Tingting Yang, Bingqian Jiang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Qunyi Guo, Pengfei Shi, Haowen Xiao, Huixian Hu, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3579.
https://doi.org/10.1182/blood-2023-189068
Published: 2023
Journal Articles

A Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Free
Junyuan Qi, Lin Song, Xudong Wei, Zhimin Zhai, Anyou Wang, Daozi Jiang, Yang Liang, Fei Li, Zhongxing Jiang, Xuejun Zhang, Qunyi Guo, Hongmei Jing, Yajing Xu, Xiangmin Tong, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2908.
https://doi.org/10.1182/blood-2023-183088
Published: 2023
Journal Articles

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Free
Bingqian Jiang, Tingting Yang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Pengfei Shi, Haowen Xiao, Huixian Hu, Qunyi Guo, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2228.
https://doi.org/10.1182/blood-2023-184668
Published: 2023
Journal Articles

Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Free
Wen Lei, Zhao Ai, Hui Liu, Chunmei Yang, Cheng Wei, Shanshan Guo, Zhilu Chen, Qunyi Guo, Linjie Li, Mingzhe Zhao, Gongqiang Wu, Jinyi Zhang, Jimin Gao, Wenbin Qian
Journal: Blood
Blood (2022) 140 (Supplement 1): 12722.
https://doi.org/10.1182/blood-2022-156635
Published: 2022
Journal Articles

The Effect of CAHB on Myelodysplastic Syndrome In Vitro and Its Application in a Prospective Clinical Trial.

Free
Zhen Cai, PhD, MD, Jingsong He, PhD, M.D., Jiming Shi, M.D., Li Li, M.D., Xiaoyan Han, M.D., Qunyi Guo, M.D., Hui Zhou, M.D., Buwen Zhang, M.D., He Huang, PhD, M.D., Maofang Lin, M.D.
Journal: Blood
Blood (2007) 110 (11): 4628.
https://doi.org/10.1182/blood.V110.11.4628.4628
Published: 2007